| Hydrogel-based drug delivery nanosystems for the treatment of brain tumors J Basso, A Miranda, S Nunes, T Cova, J Sousa, C Vitorino, A Pais Gels 4 (3), 62, 2018 | 113 | 2018 |
| Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 JD Steinmetz, KM Seeher, N Schiess, E Nichols, B Cao, C Servili, ... The Lancet Neurology 23 (4), 344-381, 2024 | 112 | 2024 |
| Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the … M Naghavi, KL Ong, A Aali, HS Ababneh, YH Abate, C Abbafati, ... The Lancet, 2024 | 104 | 2024 |
| Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the … AE Schumacher, HH Kyu, A Aali, C Abbafati, J Abbas, ... The Lancet, 2024 | 90 | 2024 |
| Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease … M Brauer, GA Roth, AY Aravkin, P Zheng, KH Abate, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2162-2203, 2024 | 68 | 2024 |
| Repurposing drugs for glioblastoma: from bench to bedside J Basso, A Miranda, J Sousa, A Pais, C Vitorino Cancer letters 428, 173-183, 2018 | 60 | 2018 |
| Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021 SE Vollset, HS Ababneh, YH Abate, C Abbafati, R Abbasgholizadeh, ... The Lancet 403 (10440), 2204-2256, 2024 | 30 | 2024 |
| Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021 NV Bhattacharjee, AE Schumacher, A Aali, YH Abate, R Abbasgholizadeh, ... The Lancet, 2024 | 30 | 2024 |
| Analytical Quality by Design (AQbD) as a multiaddressable platform for co-encapsulating drug assays J Basso, M Mendes, TFGG Cova, JJ Sousa, AACC Pais, C Vitorino Analytical Methods 10 (47), 5659-5671, 2018 | 28 | 2018 |
| Biomimeting ultra-small lipid nanoconstructs for glioblastoma treatment: A computationally guided experimental approach M Mendes, J Basso, J Silva, T Cova, J Sousa, A Pais, C Vitorino International Journal of Pharmaceutics 587, 119661, 2020 | 20 | 2020 |
| A Stepwise Framework for the Systematic Development of Lipid Nanoparticles J Basso, M Mendes, T Cova, J Sousa, A Pais, A Fortuna, R Vitorino, ... Biomolecules 12 (2), 223, 2022 | 19 | 2022 |
| Peptide-lipid nanoconstructs act site-specifically towards glioblastoma growth impairment J Basso, M Mendes, J Silva, J Sereno, T Cova, R Oliveira, A Fortuna, ... European Journal of Pharmaceutics and Biopharmaceutics 155, 177-189, 2020 | 17 | 2020 |
| Development and full validation of an HPLC methodology to quantify atorvastatin and curcumin after their intranasal co‐delivery to mice J Silva, J Basso, J Sousa, A Fortuna, C Vitorino Biomedical Chromatography 33 (10), e4621, 2019 | 14 | 2019 |
| Deciphering specific miRNAs in brain tumors: a 5-miRNA signature in glioblastoma J Basso, MG Paggi, A Fortuna, C Vitorino, R Vitorino Molecular Genetics and Genomics 297 (2), 507-521, 2022 | 10 | 2022 |
| Sorting hidden patterns in nanoparticle performance for glioblastoma using machine learning algorithms J Basso, M Mendes, J Silva, T Cova, E Luque-Michel, AF Jorge, S Grijalvo, ... International Journal of Pharmaceutics 592, 120095, 2021 | 10 | 2021 |
| Hierarchical design of hyaluronic acid-peptide constructs for glioblastoma targeting: combining insights from NMR and molecular dynamics simulations M Mendes, T Cova, J Basso, ML Ramos, R Vitorino, J Sousa, A Pais, ... Journal of Molecular Liquids 315, 113774, 2020 | 10 | 2020 |
| Expediting Disulfiram Assays through a Systematic Analytical Quality by Design Approach J Basso, ML Ramos, A Pais, R Vitorino, A Fortuna, C Vitorino Chemosensors 9 (7), 172, 2021 | 9 | 2021 |
| Nanotechnological approaches in cancer: the role of celecoxib and disulfiram J Basso, M Mendes, A Fortuna, R Vitorino, J Sousa, A Pais, C Vitorino Drug Repurposing in Cancer Therapy, 353-393, 2020 | 7 | 2020 |
| Development of a new hydrogel for the prevention of allergic contact dermatitis G Brites, J Basso, M Miranda, BM Neves, C Vitorino, MT Cruz International Journal of Pharmaceutics 628, 122265, 2022 | 6 | 2022 |
| Designing Ultra-Small Nanostructured Lipid Carriers: Critical Process Parameters M Mendes, J Basso, J Sousa, A Pais, C Vitorino Proceedings 78 (1), 50, 2020 | 5 | 2020 |
